Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Lumiliximab (anti-FceR2)
Price: Check
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

357613-86-6

357613-86-6 structure

357613-86-6 structure

Name: Lumiliximab
Chemical Name: Lumiliximab
CAS Number: 357613-86-6
Molecular Formula:
Molecular Weight: 47.75 (kDa)
Catalog: Research Areas Inflammation/Immunology
Create Date: 2023-01-15 14:34:21
Modify Date: 2024-04-02 18:36:39
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].

Name	Lumiliximab

Description	Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
Target	CD23[1]
References	[1]. Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8.

Molecular Weight	47.75 (kDa)

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.